checkpoint inhibitor — grants

Sort

10,766 grants matching “checkpoint inhibitor”

Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer

$626,815

Dohun Pyeon · Michigan State University · R01 · FY2020 · DE

Mouse models of Kras-mutant colorectal cancer

$626,771

Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2021 · CA

Mouse models of Kras-mutant colorectal cancer

$626,771

Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2023 · CA

Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer

$626,596

Eric Collisson · University Of California, San Francisco · R01 · FY2022 · CA

Understanding the role of autophagy-regulated cell death in the escape from replicative crisis

$625,994

Jan Karlseder · Salk Institute For Biological Studies · R01 · FY2023 · CA

Understanding the role of autophagy-regulated cell death in the escape from replicative crisis

$625,994

Jan Karlseder · Salk Institute For Biological Studies · R01 · FY2022 · CA

Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer

$625,911

Qingyi Wei · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA

Translation of a novel combination therapy approach for non-Hodgkin lymphoma

$625,851

Shruthi Naik · Mayo Clinic Rochester · U01 · FY2023 · CA

Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma

$625,681

Sandra P D'angelo · Sloan-Kettering Inst Can Research · R01 · FY2025 · FD

Decoding tobacco-related oral cancer ecosystem by integrative approach

$625,660

Aik Choon Tan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · DE

Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck

$625,507

Dong Moon Shin · Emory University · R01 · FY2023 · CA

Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences

$625,343

Dennis E. Discher · University Of Pennsylvania · U01 · FY2025 · CA

Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer

$625,125

Eric Collisson · University Of California, San Francisco · R01 · FY2023 · CA

Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer

$625,024

Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2025 · CA

Development of a novel dual HIF-Î± inhibitor and inducer of ferroptosis for kidney cancer

$625,000

Robert Lippert · Kuda Therapeutics, Inc. · R44 · FY2023 · CA

Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer

$624,971

Gerald V Denis · Boston University Medical Campus · R01 · FY2019 · CA

Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells

$624,970

Robbie B Mailliard · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI

Signal and Transcription Factor Network interactions in Head and Neck Cancer

$624,540

Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC

NF-kappaB in pathogenesis and therapy of head and neck cancer

$624,540

Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

$624,529

Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Interrogating the role of arachidonic acid metabolism in modulating the tumor immune microenvironment as a novel path to therapeutic intervention

$624,518

Timothy J Yeatman · University Of South Florida · U01 · FY2024 · CA

Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer

Mouse models of Kras-mutant colorectal cancer

Mouse models of Kras-mutant colorectal cancer

Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer

Understanding the role of autophagy-regulated cell death in the escape from replicative crisis

Understanding the role of autophagy-regulated cell death in the escape from replicative crisis

Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer

Translation of a novel combination therapy approach for non-Hodgkin lymphoma

Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma

Decoding tobacco-related oral cancer ecosystem by integrative approach

Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck

Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences

Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer

Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer

Development of a novel dual HIF-Î± inhibitor and inducer of ferroptosis for kidney cancer

Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer

Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells

Signal and Transcription Factor Network interactions in Head and Neck Cancer

NF-kappaB in pathogenesis and therapy of head and neck cancer

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Interrogating the role of arachidonic acid metabolism in modulating the tumor immune microenvironment as a novel path to therapeutic intervention

Clinical Protocol and Data Management

MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer

Spatially resolved, single cell biomarkers of B cell lymphoma

Peptoid conjugates targeting prostate cancer

Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells